GLPwatch
Basal insulin or longacting GLP-1 receptor agonists-making the right choice.
Lancet Diabetes Endocrinol · 2014
Last updated 2026-05-28| Journal | Lancet Diabetes Endocrinol, 2014 |
|---|---|
| Citations | 3 |
| Relative citation ratio | 0.09 |
| NIH percentile | 7 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 24731676 ↗